3/27
11:27 am
bmea
Biomea Fusion (BMEA) had its price target raised by Citigroup Inc. from $6.00 to $7.00. They now have a "buy" rating on the stock.
Neutral
Report
Biomea Fusion (BMEA) had its price target raised by Citigroup Inc. from $6.00 to $7.00. They now have a "buy" rating on the stock.
3/27
06:52 am
bmea
Can Biomea Fusion (NASDAQ:BMEA) Afford To Invest In Growth? [Yahoo! Finance]
Low
Report
Can Biomea Fusion (NASDAQ:BMEA) Afford To Invest In Growth? [Yahoo! Finance]
3/25
11:17 am
bmea
Biomea Fusion (BMEA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $12.00 price target on the stock.
Low
Report
Biomea Fusion (BMEA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $12.00 price target on the stock.
3/24
05:11 pm
bmea
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights [Yahoo! Finance]
Medium
Report
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights [Yahoo! Finance]
3/24
04:05 pm
bmea
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
Medium
Report
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
3/14
05:05 am
bmea
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 [Yahoo! Finance]
High
Report
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 [Yahoo! Finance]
3/14
04:30 am
bmea
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
High
Report
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
3/13
03:46 am
bmea
Biomea Fusion Details Diabetes, Obesity Pipeline at Citizens Conference, Sees Cash Runway to Q1 2027 [Yahoo! Finance]
Medium
Report
Biomea Fusion Details Diabetes, Obesity Pipeline at Citizens Conference, Sees Cash Runway to Q1 2027 [Yahoo! Finance]
2/26
11:40 pm
bmea
Biomea Fusion Spotlights Durable Diabetes Data, Oral GLP-1 Weight-Loss Program at Oppenheimer Conf. [Yahoo! Finance]
Medium
Report
Biomea Fusion Spotlights Durable Diabetes Data, Oral GLP-1 Weight-Loss Program at Oppenheimer Conf. [Yahoo! Finance]
2/19
07:34 am
bmea
Biomea Fusion to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Biomea Fusion to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/19
07:00 am
bmea
Biomea Fusion to Participate at Upcoming Investor Conferences
Low
Report
Biomea Fusion to Participate at Upcoming Investor Conferences
1/24
08:42 am
bmea
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% [Yahoo! Finance]
Medium
Report
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% [Yahoo! Finance]
1/19
08:26 am
bmea
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target [Yahoo! Finance]
Low
Report
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target [Yahoo! Finance]
1/13
10:58 am
bmea
Biomea Fusion (NASDAQ:BMEA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Medium
Report
Biomea Fusion (NASDAQ:BMEA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
1/13
08:03 am
bmea
Biomea Fusion (NASDAQ:BMEA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
Neutral
Report
Biomea Fusion (NASDAQ:BMEA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
1/12
08:00 am
bmea
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
Low
Report
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones